Cargando…

A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common malignant tumor that seriously affects human health. Previous studies have indicated that abnormal levels of glycosylation promote progression and poor prognosis of lung cancer. Thus, the present study aimed to explore the prognostic signatur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jin-xiao, Chen, Qian, Gao, Wei, Chen, Da, Qian, Xin-yu, Bi, Jin-qiao, Lin, Xing-chen, Han, Bing-bing, Liu, Jin-shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793550/ https://www.ncbi.nlm.nih.gov/pubmed/36575396 http://dx.doi.org/10.1186/s12859-022-05109-8

Ejemplares similares

5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023)

Signatures of malignant cells and novel therapeutic targets revealed by single‐cell sequencing in lung adenocarcinoma
por: Liang, Jiaqi, et al.
Publicado: (2022)

Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma
por: Duan, Jin, et al.
Publicado: (2021)

A Novel Secreted Protein-Related Gene Signature Predicts Overall Survival and Is Associated With Tumor Immunity in Patients With Lung Adenocarcinoma
por: Chen, Shuaijun, et al.
Publicado: (2022)

Tumor microenvironment related novel signature predict lung adenocarcinoma survival
por: Chen, Juan, et al.
Publicado: (2021)

A network-based signature to predict the survival of non-smoking lung adenocarcinoma
por: Mao, Qixing, et al.
Publicado: (2018)

Comprehensive Analysis of a Novel Immune-Related Gene Signature in Lung Adenocarcinoma
por: Feng, Hongxiang, et al.
Publicado: (2022)

An expression signature model to predict lung adenocarcinoma-specific survival
por: Shi, Xiaoshun, et al.
Publicado: (2018)

A novel necroptosis signature for predicting survival in lung adenocarcinoma
por: Zang, Kui, et al.
Publicado: (2023)

Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Identification of an eight-gene prognostic signature for lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis
por: Wang, Yanfang, et al.
Publicado: (2019)

Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma
por: Tian, Qi, et al.
Publicado: (2021)

A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma
por: Zhang, Xiao, et al.
Publicado: (2022)

A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma
por: Chen, Mingwei, et al.
Publicado: (2017)

A novel telomere-related gene prognostic signature for survival and drug treatment efficiency prediction in lung adenocarcinoma
por: Chen, Haiming, et al.
Publicado: (2023)

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung
por: He, Si-Yu, et al.
Publicado: (2019)

Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma
por: Yu, Qian, et al.
Publicado: (2022)

Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
por: Zhu, Qianjun, et al.
Publicado: (2023)

A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma
por: Gao, Hongli, et al.
Publicado: (2022)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
por: Zeng, Zhimin, et al.
Publicado: (2022)

A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data
por: Yang, Zhiyu, et al.
Publicado: (2020)

A novel epithelial-mesenchymal transition (EMT)-related gene signature of predictive value for the survival outcomes in lung adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2022)

A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma
por: Jin, Xing, et al.
Publicado: (2022)

Characterization of the alternative splicing landscape in lung adenocarcinoma reveals novel prognosis signature associated with B cells
por: Shao, Ming-Ming, et al.
Publicado: (2023)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

A novel gene expression signature-based on B-cell proportion to predict prognosis of patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Potential Genes Associated with the Survival of Lung Adenocarcinoma Were Identified by Methylation
por: Shen, Ziyuan, et al.
Publicado: (2020)

An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma
por: Xu, Qian, et al.
Publicado: (2021)

A Novel Mitochondrial-Related Nuclear Gene Signature Predicts Overall Survival of Lung Adenocarcinoma Patients
por: Zhang, Xiangwei, et al.
Publicado: (2021)

A novel CpG-based signature for survival prediction of lung adenocarcinoma patients
por: Zheng, Rongjiong, et al.
Publicado: (2020)

A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma
por: Jiang, Zhou, et al.
Publicado: (2022)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

The clinical significances of the abnormal expressions of Piwil1 and Piwil2 in colonic adenoma and adenocarcinoma
por: Wang, Hai-Ling, et al.
Publicado: (2015)

A Novel Predictive Model Incorporating Ferroptosis-Related Gene Signatures for Overall Survival in Patients with Lung Adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2022)

Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma
por: Song, Qian, et al.
Publicado: (2019)

A novel microRNA signature predicts survival in stomach adenocarcinoma
por: Ding, Bowen, et al.
Publicado: (2017)

A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
por: Zhang, Kai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6rrc2dr90jnaumbu567b9aa2sv